HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Ofloxacin otic solution

TERMINATED · PHASE4 · Otitis Media

There was limited enrollment in the study.

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.